Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival
Open Access
- 1 January 2002
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 8 (6) , 987-993
- https://doi.org/10.3748/wjg.v8.i6.987
Abstract
Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survivalKeywords
This publication has 66 references indexed in Scilit:
- Abnormal expression of E-cadherin and β-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancerBritish Journal of Surgery, 2002
- Abnormal expression of E-cadherin and β-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancerBritish Journal of Surgery, 2002
- Soluble E-cadherin is a valid prognostic marker in gastric carcinomaGut, 2001
- Somatic β-catenin mutation in gastric carcinoma – an infrequent event that is not specific for microsatellite instabilityCancer Letters, 2001
- Cooccurrence of Reduced Expression of α-Catenin and Overexpression of p53 Is a Predictor of Lymph Node Metastasis in Early Gastric CancerOncology, 1999
- E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomasEuropean Journal Of Cancer Prevention, 1999
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly.The Journal of cell biology, 1994
- Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasivenessBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor roleCell, 1991